Amy Holden

Amy Holden is a seasoned professional in the pharmaceutical industry, currently serving as the Sr. National Payer Account Director at Daiichi Sankyo, Inc. since July 2023. Prior experience includes positions as Director of Corporate Accounts at Idorsia Pharmaceuticals Ltd and Director of National Accounts at Zogenix, Inc. Notably, Amy held multiple roles at Sanofi Genzyme, including National Account Director for Oncology/Transplant, and spent nearly two decades at Takeda in various capacities, including Corporate Account Director and Regional Sales Director. Throughout the career, Amy has demonstrated expertise in specialty areas such as Inflammatory Bowel Disease, CNS, and Diabetes, earning recognition with multiple Cresset Awards for outstanding performance. Amy’s educational background includes a BS in Biology from the University of South Carolina.